Brief: UK's MHRA Approves Vimkunya Vaccine For Chikungunya In People Aged 12 And Older
May 1 (Reuters) - UK's MHRA: UK'S MHRA: VIMKUNYA VACCINE APPROVED TO PREVENT DISEASE CAUSED BY CHIKUNGUNYA VIRUS IN PEOPLE 12 YEARS OF AGE AND OLDER Further company coverage: BAVA.CO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Gets Smallpox/Mpox Vaccine Supply Contract
Brief: Bavarian Nordic Secures Additional Government Contract For The Supply Of Smallpox/Mpox Vaccine
Brief: Bavarian Nordic Launches Final Tranche Of Buy-Back Program
Bavarian Nordic falls as high costs, lower vaccine sales hit Q1 results
Bavarian Nordic Q1 revenue falls as Public Preparedness unit sales decline